• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病运动功能障碍的病理生理学:药物治疗与康复的理论基础

Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation.

作者信息

Magrinelli Francesca, Picelli Alessandro, Tocco Pierluigi, Federico Angela, Roncari Laura, Smania Nicola, Zanette Giampietro, Tamburin Stefano

机构信息

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134 Verona, Italy.

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134 Verona, Italy; Neuromotor and Cognitive Rehabilitation Research Centre, University of Verona, Piazzale Scuro 10, 37134 Verona, Italy.

出版信息

Parkinsons Dis. 2016;2016:9832839. doi: 10.1155/2016/9832839. Epub 2016 Jun 6.

DOI:10.1155/2016/9832839
PMID:27366343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4913065/
Abstract

Cardinal motor features of Parkinson's disease (PD) include bradykinesia, rest tremor, and rigidity, which appear in the early stages of the disease and largely depend on dopaminergic nigrostriatal denervation. Intermediate and advanced PD stages are characterized by motor fluctuations and dyskinesia, which depend on complex mechanisms secondary to severe nigrostriatal loss and to the problems related to oral levodopa absorption, and motor and nonmotor symptoms and signs that are secondary to marked dopaminergic loss and multisystem neurodegeneration with damage to nondopaminergic pathways. Nondopaminergic dysfunction results in motor problems, including posture, balance and gait disturbances, and fatigue, and nonmotor problems, encompassing depression, apathy, cognitive impairment, sleep disturbances, pain, and autonomic dysfunction. There are a number of symptomatic drugs for PD motor signs, but the pharmacological resources for nonmotor signs and symptoms are limited, and rehabilitation may contribute to their treatment. The present review will focus on classical notions and recent insights into the neuropathology, neuropharmacology, and neurophysiology of motor dysfunction of PD. These pieces of information represent the basis for the pharmacological, neurosurgical, and rehabilitative approaches to PD.

摘要

帕金森病(PD)的主要运动特征包括运动迟缓、静止性震颤和肌强直,这些症状出现在疾病早期,主要取决于多巴胺能黑质纹状体去神经支配。帕金森病的中期和晚期以运动波动和异动症为特征,这取决于严重黑质纹状体缺失继发的复杂机制以及与口服左旋多巴吸收相关的问题,还包括明显多巴胺能缺失和多系统神经变性伴非多巴胺能通路损伤继发的运动和非运动症状及体征。非多巴胺能功能障碍导致运动问题,包括姿势、平衡和步态障碍以及疲劳,还导致非运动问题,包括抑郁、冷漠、认知障碍、睡眠障碍、疼痛和自主神经功能障碍。有多种用于治疗帕金森病运动体征的对症药物,但用于治疗非运动体征和症状的药物资源有限,康复治疗可能有助于其治疗。本综述将聚焦于帕金森病运动功能障碍的神经病理学、神经药理学和神经生理学的经典概念及最新见解。这些信息是帕金森病药物治疗、神经外科治疗和康复治疗方法的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be2c/4913065/6ab5e546a34e/PD2016-9832839.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be2c/4913065/1cc29f87b3de/PD2016-9832839.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be2c/4913065/6ab5e546a34e/PD2016-9832839.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be2c/4913065/1cc29f87b3de/PD2016-9832839.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be2c/4913065/6ab5e546a34e/PD2016-9832839.002.jpg

相似文献

1
Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation.帕金森病运动功能障碍的病理生理学:药物治疗与康复的理论基础
Parkinsons Dis. 2016;2016:9832839. doi: 10.1155/2016/9832839. Epub 2016 Jun 6.
2
Nonmotor features of Parkinson's disease subtypes.帕金森病亚型的非运动特征。
Mov Disord. 2016 Aug;31(8):1095-102. doi: 10.1002/mds.26510. Epub 2016 Feb 10.
3
New pharmacological options for treating advanced Parkinson's disease.治疗晚期帕金森病的新药理学选择。
Clin Ther. 2013 Oct;35(10):1640-52. doi: 10.1016/j.clinthera.2013.08.011. Epub 2013 Sep 5.
4
The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.帕金森病运动波动的隐匿姊妹篇:非运动波动综述
Mov Disord. 2016 Aug;31(8):1080-94. doi: 10.1002/mds.26731. Epub 2016 Jul 19.
5
Non-motor extranigral signs and symptoms in Parkinson's disease.帕金森病的非运动性外显体征和症状。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S6-12. doi: 10.1016/S1353-8020(09)70770-9.
6
Neuroprotective approaches to halt Parkinson's disease progression.神经保护方法以阻止帕金森病的进展。
Neurochem Int. 2022 Sep;158:105380. doi: 10.1016/j.neuint.2022.105380. Epub 2022 Jun 17.
7
Parkinson's disease: Diagnosis and appreciation of comorbidities.帕金森病:合并症的诊断与评估
Handb Clin Neurol. 2019;167:257-277. doi: 10.1016/B978-0-12-804766-8.00014-5.
8
Non-dopaminergic treatments for motor control in Parkinson's disease.帕金森病运动控制的非多巴胺能治疗方法。
Drugs. 2013 Sep;73(13):1405-15. doi: 10.1007/s40265-013-0105-4.
9
Emergence of nonmotor symptoms as the focus of research and treatment of Parkinson's disease: introduction to the special section on nonmotor dysfunctions in Parkinson's disease.非运动症状成为帕金森病研究与治疗重点:帕金森病非运动功能障碍专题介绍
Behav Neurosci. 2013 Apr;127(2):135-8. doi: 10.1037/a0032142.
10
Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.帕金森病运动和非运动特征的进展及其对治疗的反应。
Br J Clin Pharmacol. 2012 Aug;74(2):267-83. doi: 10.1111/j.1365-2125.2012.04192.x.

引用本文的文献

1
Impairment in the behavioral control of body sway, gaze shift, and mental workload in Parkinson's disease.帕金森病患者在身体摆动、目光转移和心理负荷行为控制方面的损害。
Sci Rep. 2025 Aug 19;15(1):30354. doi: 10.1038/s41598-025-12878-8.
2
Prediction of Parkinson Disease Using Long-Term, Short-Term Acoustic Features Based on Machine Learning.基于机器学习的长期和短期声学特征预测帕金森病
Brain Sci. 2025 Jul 10;15(7):739. doi: 10.3390/brainsci15070739.
3
The Use of Posturography in Vestibular Evaluation of Neurodegenerative Disorders: Diagnostic and Rehabilitative Impacts.

本文引用的文献

1
Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's disease: a pilot, single-blind, randomized controlled trial.跑步机训练对轻至中度帕金森病患者认知和运动特征的影响:一项先导性、单盲、随机对照试验
Funct Neurol. 2016 Jan-Mar;31(1):25-31. doi: 10.11138/fneur/2016.31.1.025.
2
Intrinsic circuits of the striatum: Complexity and clinical correlations.纹状体的内在回路:复杂性与临床关联
Neurology. 2016 Apr 19;86(16):1531-42. doi: 10.1212/WNL.0000000000002599. Epub 2016 Mar 23.
3
Relearning of Writing Skills in Parkinson's Disease After Intensive Amplitude Training.
姿势描记法在神经退行性疾病前庭评估中的应用:诊断和康复影响
Cureus. 2025 Jul 25;17(7):e88752. doi: 10.7759/cureus.88752. eCollection 2025 Jul.
4
Parkinsonism disrupts cortical function by dysregulating oscillatory, network and synaptic activity of parvalbumin positive interneurons.帕金森症通过失调小白蛋白阳性中间神经元的振荡、网络和突触活动来破坏皮质功能。
NPJ Parkinsons Dis. 2025 Jul 1;11(1):194. doi: 10.1038/s41531-025-01052-6.
5
Use of Smartphones and Wrist-Worn Devices for Motor Symptoms in Parkinson's Disease: A Systematic Review of Commercially Available Technologies.使用智能手机和腕戴设备监测帕金森病运动症状:对商用技术的系统评价
Sensors (Basel). 2025 Jun 14;25(12):3732. doi: 10.3390/s25123732.
6
Unsupervised subtyping of motor dysfunction of Parkinson's disease and its structural brain imaging correlates.帕金森病运动功能障碍的无监督亚型分类及其脑结构成像相关性。
Neuroimage Rep. 2025 Mar 1;5(1):100246. doi: 10.1016/j.ynirp.2025.100246. eCollection 2025 Mar.
7
Parkinson's disease: exploring the systemic immune mechanisms through molecular investigations.帕金森病:通过分子研究探索全身免疫机制
Inflammopharmacology. 2025 Jun 23. doi: 10.1007/s10787-025-01816-9.
8
Effects of boxing interventions on physical fitness and health-related quality of life in older people with Parkinson's disease: a systematic review with meta-analysis.拳击干预对帕金森病老年人身体素质及健康相关生活质量的影响:一项Meta分析的系统评价
Front Public Health. 2025 Jun 6;13:1589512. doi: 10.3389/fpubh.2025.1589512. eCollection 2025.
9
Immediate effects of extracorporeal radial pressure wave therapy on dystonia, static plantar pressure distribution, and balance in patients with Parkinson's disease.体外径向压力波疗法对帕金森病患者肌张力障碍、静态足底压力分布及平衡的即时影响。
Front Aging Neurosci. 2025 May 19;17:1539225. doi: 10.3389/fnagi.2025.1539225. eCollection 2025.
10
Ferroptosis role in complexity of cell death: unrevealing mechanisms in Parkinson's disease and therapeutic approaches.铁死亡在细胞死亡复杂性中的作用:揭示帕金森病的机制及治疗方法
Inflammopharmacology. 2025 Mar;33(3):1271-1287. doi: 10.1007/s10787-025-01672-7. Epub 2025 Feb 25.
帕金森病患者在强化幅度训练后书写技能的重新学习
Mov Disord. 2016 Aug;31(8):1209-16. doi: 10.1002/mds.26565. Epub 2016 Mar 17.
4
Screening for Mild Cognitive Impairment in Parkinson's Disease: Comparison of the Italian Versions of Three Neuropsychological Tests.帕金森病轻度认知障碍的筛查:三种神经心理学测试意大利语版本的比较。
Parkinsons Dis. 2015;2015:681976. doi: 10.1155/2015/681976. Epub 2015 Nov 8.
5
Apathy: a practical guide for neurologists.《冷漠:神经科医生实用指南》
Pract Neurol. 2016 Feb;16(1):42-7. doi: 10.1136/practneurol-2015-001232. Epub 2015 Oct 26.
6
Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.盐酸羟考酮-纳洛酮缓释片治疗帕金森病患者重度疼痛(PANDA)的双盲、随机、安慰剂对照试验。
Lancet Neurol. 2015 Dec;14(12):1161-70. doi: 10.1016/S1474-4422(15)00243-4. Epub 2015 Oct 19.
7
Basal Ganglia Circuits as Targets for Neuromodulation in Parkinson Disease.基底神经节回路作为帕金森病神经调节的靶点。
JAMA Neurol. 2015 Nov;72(11):1354-60. doi: 10.1001/jamaneurol.2015.2397.
8
New clinical trials for nonmotor manifestations of Parkinson's disease.帕金森病非运动症状的新临床试验。
Mov Disord. 2015 Sep 15;30(11):1490-504. doi: 10.1002/mds.26415.
9
Neurorehabilitation for Parkinson's disease: Future perspectives for behavioural adaptation.帕金森病的神经康复:行为适应的未来展望
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S73-7. doi: 10.1016/j.parkreldis.2015.08.031. Epub 2015 Sep 8.
10
Rehabilitation for Parkinson's disease: Current outlook and future challenges.帕金森病的康复治疗:当前现状与未来挑战
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S60-4. doi: 10.1016/j.parkreldis.2015.09.005. Epub 2015 Sep 3.